Karyopharm Therapeutics Inc. is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. As an organization, Karyopharm is on a mission to improve lives and defeat cancer. In its role as leaders in XPO1 inhibition, Karyopharm delivers on its mission by creating a focused pipeline that targets multiple high unmet need cancer indications, including multiple myeloma, endometrial cancer, myelofibrosis, and diffuse large B-cell lymphoma (DLBCL).
View Top Employees from Karyopharm Therapeutics Inc.| Website | http://www.karyopharm.com |
| Ticker | KPTI |
| Revenue | $40 million |
| Funding | $1 billion |
| Employees | 524 (524 on RocketReach) |
| Founded | 2008 |
| Address | 85 Wells Avenue, Newton, Massachusetts 02459, US |
| Phone | (617) 658-0600 |
| Technologies |
JavaScript,
HTML,
PHP
+47 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Health Care, Healthcare, Medical, Pharmaceutical |
| Web Rank | 3 Million |
| Keywords | Cancer Drugs, Cancer Treatment |
| Competitors | AB Science, Deciphera Pharmaceuticals, G1 Therapeutics, Inc., Reata Pharmaceuticals, Inc., Relypsa |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 325412 Companies |
Looking for a particular Karyopharm Therapeutics Inc. employee's phone or email?
Karyopharm Therapeutics Inc. Questions
The Karyopharm Therapeutics Inc. annual revenue was $40 million in 2024.
Richard Paulson is the President and Chief Executive Officer of Karyopharm Therapeutics Inc..
524 people are employed at Karyopharm Therapeutics Inc..
Karyopharm Therapeutics Inc. is based in Newton, Massachusetts.
The NAICS codes for Karyopharm Therapeutics Inc. are [3254, 32541, 32, 325, 325412].
The SIC codes for Karyopharm Therapeutics Inc. are [283, 28].
Top Karyopharm Therapeutics Inc. Employees
-
45+
-
35
-
ViewPatricia Judson
Senior Vice President and Head Medical Strategy at Karyopharm Therapeutics Inc.
Philadelphia, Pennsylvania, United States45+ -
41
Related Companies
